Hence, the purpose of this study was to investigate EGFR mutations in the context of carcinoembryonic antigen levels and to assess the prognostic value of such mutations in patients with pathological T1 lung adenocarcinoma. This evidence concerns the gene CEACAM5 and lung adenocarcinoma.